118 related articles for article (PubMed ID: 8126346)
1. The interaction of ethanol with the cognitive enhancers tacrine, physostigmine, and AIT-082.
Ritzmann RF; Glasky A; Steinberg A; Melchior CL
J Gerontol; 1994 Mar; 49(2):B51-3. PubMed ID: 8126346
[TBL] [Abstract][Full Text] [Related]
2. Effect of AIT-082, a purine analog, on working memory in normal and aged mice.
Glasky AJ; Melchior CL; Pirzadeh B; Heydari N; Ritzmann RF
Pharmacol Biochem Behav; 1994 Feb; 47(2):325-9. PubMed ID: 8146224
[TBL] [Abstract][Full Text] [Related]
3. Reversal of cycloheximide-induced memory disruption by AIT-082 (Neotrofin) is modulated by, but not dependent on, adrenal hormones.
Yan R; Nguyen Q; Gonzaga J; Johnson M; Ritzmann RF; Taylor EM
Psychopharmacology (Berl); 2003 Apr; 166(4):400-7. PubMed ID: 12605287
[TBL] [Abstract][Full Text] [Related]
4. Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats.
Yoshida S; Suzuki N
Eur J Pharmacol; 1993 Nov; 250(1):117-24. PubMed ID: 8119309
[TBL] [Abstract][Full Text] [Related]
5. Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models.
Rupniak NM; Field MJ; Samson NA; Steventon MJ; Iversen SD
Neurobiol Aging; 1990; 11(6):609-13. PubMed ID: 2280804
[TBL] [Abstract][Full Text] [Related]
6. An investigation of the effect of tacrine and physostigmine on spatial working memory deficits in the olfactory bulbectomised rat.
Hallam KT; Horgan JE; McGrath C; Norman TR
Behav Brain Res; 2004 Aug; 153(2):481-6. PubMed ID: 15265646
[TBL] [Abstract][Full Text] [Related]
7. Effect of age and strain on working memory in mice as measured by win-shift paradigm.
Ritzmann RF; Kling A; Melchior CL; Glasky AJ
Pharmacol Biochem Behav; 1993 Apr; 44(4):805-7. PubMed ID: 8469692
[TBL] [Abstract][Full Text] [Related]
8. Differentiated cerebrovascular effects of physostigmine and tacrine in cortical areas deafferented from the nucleus basalis magnocellularis suggest involvement of basalocortical projections to microvessels.
Peruzzi P; von Euw D; Lacombe P
Ann N Y Acad Sci; 2000 Apr; 903():394-406. PubMed ID: 10818530
[TBL] [Abstract][Full Text] [Related]
9. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum.
Clarke PB; Reuben M; el-Bizri H
Br J Pharmacol; 1994 Mar; 111(3):695-702. PubMed ID: 8019748
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines.
Lahiri DK; Farlow MR
J Mol Neurosci; 1996; 7(1):41-9. PubMed ID: 8835781
[TBL] [Abstract][Full Text] [Related]
11. Tacrine and physostigmine block nicotinic receptors in Xenopus oocytes injected with Torpedo electroplaque membranes.
Cantí C; Bodas E; Marsal J; Solsona C
Eur J Pharmacol; 1998 Dec; 363(2-3):197-202. PubMed ID: 9881590
[TBL] [Abstract][Full Text] [Related]
12. Effects of a memory enhancing peptide on cognitive abilities of brain-lesioned mice: additivity with huperzine A and relative potency to tacrine.
Xu Z; Zheng H; Law SL; Dong So D; Han Y; Xue H
J Pept Sci; 2006 Jan; 12(1):72-8. PubMed ID: 15942937
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of AIT-082 in healthy elderly volunteers.
Grundman M; Farlow M; Peavy G; Kim HT; Capparelli E; Schultz AN; Salmon DP; Ferris SH; Mobs R; Thomas RG; Schafer K; Campbell K; Hake AM; Schoos B; Thal LJ;
J Mol Neurosci; 2002 Jun; 18(3):283-93. PubMed ID: 12059047
[TBL] [Abstract][Full Text] [Related]
14. Tacrine inhibits nicotinic secretory and current responses in adrenal chromaffin cells.
Sugawara T; Ohta T; Asano T; Ito S; Nakazato Y
Eur J Pharmacol; 1997 Jan; 319(1):123-30. PubMed ID: 9030907
[TBL] [Abstract][Full Text] [Related]
15. [Effects of amiridin and tacrine, drugs effective in Alzheimer's disease, on synaptosomal uptake of neuromediators].
Burov IuV; Baĭmanov TD; Maĭsov NI
Biull Eksp Biol Med; 1992 Apr; 113(4):379-81. PubMed ID: 1356507
[TBL] [Abstract][Full Text] [Related]
16. Effect of a memory-enhancing drug, AIT-082, on the level of synaptophysin.
Lahiri DK; Ge YW; Farlow MR
Ann N Y Acad Sci; 2000 Apr; 903():387-93. PubMed ID: 10818529
[TBL] [Abstract][Full Text] [Related]
17. Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs.
Zwart R; van Kleef RG; Gotti C; Smulders CJ; Vijverberg HP
J Neurochem; 2000 Dec; 75(6):2492-500. PubMed ID: 11080202
[TBL] [Abstract][Full Text] [Related]
18. Effects of velnacrine, tacrine and physostigmine on tetanic twitch responses at the rat neuromuscular junction.
Bosch F; Morales M; Badia A; Baños JE
Eur J Pharmacol; 1992 Nov; 222(1):163-6. PubMed ID: 1468493
[TBL] [Abstract][Full Text] [Related]
19. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
Shannon HE; Bemis KG; Hendrix JC; Ward JS
J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tetrahydroaminoacridine and physostigmine on scopolamine-induced free swim behavior in the rat.
Dokla CP; Rydelek-Fitzgerald L
Psychopharmacology (Berl); 1991; 103(2):240-3. PubMed ID: 2027924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
